Management: 
The patient started SLE treatment on 30/12/2020 after two months of her initial symptoms. She was started on pulse steroid 1000 mg of methylprednisolone daily for five days, followed by oral prednisone 60mg daily. The patient was started on Plaquenil 400mg PO OD and cyclophosphamide 2mg/Kg PO OD. She was prescribed phenytoin as an antiepileptic medication. However, she developed an allergy to it, so she was shifted on levetiracetam, became more agitated, turned to Lamictal 25mg PO BID gradually, and weaned off levetiracetam, which made her better in terms of agitation. She was prescribed Bisoprolol 5mg PO BID for her sinus tachycardia. After three months, her medical situation improved, with no more seizures or psychosis. On 08/06/2021, cyclophosphamide was stopped, started on Cellcept 1000 mg PO BID, and gradually reduced her steroid dose to 15mg PO OD. Since she was on steroids, her weight increased, and her lipid profile revealed an increase in total cholesterol and LDL, so she has been prescribed atorvastatin and advised about diet. She had a thyroid antibodies test and was negative, so she was advised to do FNA of the thyroid to check for malignancy, and the biopsy results were unremarkable for malignancy. At 02/03/2022 the patient was on prednisolone 5 mg PO OD, Cellcept 1000 PO BID , Plaquenil 400 mg PO OD , atorvastatin 10 mg PO OD , Lamictal 25 mg PO BID , Bisoprolol 5 mg PO PD, and Ca and vitamin D tablets. She had no active complaints, and she was doing fine.